ViroGates A/S (CPH:VIRO)

Denmark flag Denmark · Delayed Price · Currency is DKK
11.95
-0.35 (-2.85%)
Feb 16, 2026, 1:43 PM CET
Market Cap114.17M +13.5%
Revenue (ttm)8.11M +11.9%
Net Income-12.39M
EPS-1.60
Shares Out9.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume216
Average Volume1,579
Open12.20
Previous Close12.30
Day's Range11.95 - 12.20
52-Week Range5.98 - 17.40
Beta0.71
RSI47.13
Earnings DateMar 26, 2026

About ViroGates

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer. The company’s product includes suPARnostic TurbiLatex, a latex particle-enhan... [Read more]

Sector Healthcare
Founded 2000
Employees 7
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol VIRO
Full Company Profile

Financial Performance

In 2024, ViroGates's revenue was 7.14 million, an increase of 2.22% compared to the previous year's 6.99 million. Losses were -14.35 million, 18.6% more than in 2023.

Financial Statements